The Role of p53 in Metabolic Regulation
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
The metabolic changes that occur in a cancer cell have been studied for a few decades, but our appreciation of the complexity and importance of those changes is now being realized. The metabolic switch from oxidative phosphorylation to aerobic glycolysis provides intermediates for cell growth and division and is regulated by both oncogenes and tumor suppressor genes. The p53 tumor suppressor gene has long been shown to play key roles in responding to DNA damage, hypoxia, and oncogenic activation. However, now p53 has added the ability to mediate metabolic changes in cells through the regulation of energy metabolism and oxidative stress to its repertoire of activities. It is therefore the focus of this review to discuss the metabolic pathways regulated by p53 and their cooperation in controlling cancer cell metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to stopping senescent cell proliferation, p53 and RB mediate senescence-related metabolic changes by balancing their effects on glycolysis: p53 restricts the glycolysis activity of senescent cells through several mechanisms [226], while RB upregulates glycolytic genes, resulting in high glycolytic activity [227].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [226]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ide, T., Brown-Endres, L., Chu, K., Ongusaha, P. P., Ohtsuka, T., El-Deiry, W. S., Aaronson, S. A., & Lee, S. W. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.031 · Cited by 92
RetractedOxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441 · cited 1×
“, superoxide dismutase [SOD], glutathione peroxidase [GPx], and GSH) through protective mechanisms.(39) Even though ROS products are part of normal cellular metabolism produced mainly through the mitochondrial respiratory chain and play roles in cell proliferation and survival signaling Figure 2.”
BackgroundThe Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088 · cited 2×
“In cancer cells, AKT activation is also sufficient to drive glycolysis and lactate production and to suppress macromolecular degradation.(31) AMPK is a heterotrimeric protein consisting of 3 subunits—α, β, and γ—and drives the catabolic, energyproducing responses (i.”
BackgroundOn Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820 · cited 1×
“Pyruvate kinase–M2 (PK-M2) is the embryonic splice variant of the rate-limiting enzyme for pyruvate generation that is preferentially expressed in tumor cells and regulates the flux of carbon into ribose-5-phosphate and nucleotide synthesis via phosphotyrosine signaling.(5) Since PK-M2 can regulate the amounts of pyru…”
BackgroundA model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019 · cited 1×
“The p53 protein induces the transcription of the TIGAR gene, which lowers the intracellular concentrations of fructose-2,6-bisphosphate and thus decreases glycolysis and overall levels of intracellular reactive oxygen species (ROS).(8) The decrease in glycolysis allows for entry into the pentose phosphate pathway (PPP…”
Backgroundp53 Has a Direct Apoptogenic Role at the Mitochondria
Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P., & Moll, U. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00050-9 · Cited by 1,777 · cited 1×
“In contrast to the above target gene regulation, p53 can form a complex with the antiapoptotic proteins BCL-X L and PUMA, resulting in cytochrome c release from mitochondria and promotion of mitochondrial outer membrane permeabilization.(14) p53’s role in the regulation of cellular metabolism is complex given the many…”
Backgroundp53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650 · cited 2×
“One way p53 balances the usage of the respiratory and glycolytic pathways is through its downstream mediator, SCO2.(13) SCO2 is critical for regulating a major site of oxygen utilization in the cell, the cytochrome c oxidase (COX) complex.”
BackgroundBrugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384 · cited 1×
“REDD1 overexpression can also downregulate S6K phosphorylation in a TSC1/ TSC2-dependent manner.(33,37) Thus, p53 shuts down IGF-1/AKT and mTOR pathways through the negative regulation of IGF-BP3, PTEN, TSC2, AMPK β1, and sestrins 1 and 2 and thus plays a critical role in cell growth and division, nutritional sensing,…”
Background
Cited by
Items 101–200 of 277
Xu, F., Tautenhahn, H., Dirsch, O., & Dahmen, U. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04074-2 · Cited by 37
“2019; Puzio-Kuter 2011).”
Moriggi, M., Belloli, S., Barbacini, P., Murtaj, V., Torretta, E., Chaabane, L., Canu, T., Penati, S., Malosio, M. L., Esposito, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094680 · Cited by 34
“oxidative stress is well documented [79].”
Temaj, G., Chichiarelli, S., Telkoparan‐Akillilar, P., Saha, S., Nuhii, N., Hadžiselimović, R., & Saso, L. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116332 · Cited by 38
Hyperoxia causes senescence and increases glycolysis in cultured lung epithelial cells
Scaffa, A., Peterson, A. L., Carr, J. F., Garcia, D., Yao, H., & Dennery, P. A. (2021) · Physiological Reports · doi:10.14814/phy2.14839 · Cited by 34
“While p53 is upregulated by hyperoxia (O'Reilly et al., 1998), and it plays a role in mediating senescence and modulating glycolysis (Bensaad et al., 2006; Itahana & Itahana, 2018; Kondoh et al., 2005; Mikawa et al., 2014; Puzio- Kuter, 2011; Wang et al., 2014), it is unknown whether senescence and glycolysis are inte…”
BackgroundChowdhury, A. R., Long, A., Fuchs, S. Y., Rustgi, A. K., & Avadhani, N. G. (2016) · Oncogene · doi:10.1038/onc.2016.211 · Cited by 29
Hu, Y., Qi, Y., Liu, H., Fan, G., & Chai, Y. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.10.024 · Cited by 30
Disrupted Binding of Cystathionine γ-Lyase to p53 Promotes Endothelial Senescence
Hu, J., Leisegang, M. S., Looso, M., Drekolia, M.-K., Wittig, J., Mettner, J., Karantanou, C., Kyselova, A., Dumbović, G., Li, X., et al. (2023) · Circulation Research · doi:10.1161/circresaha.123.323084 · Cited by 31
“p53 has been proposed to regulate cellular metabolism, in particular glycolysis, 20,21 in part, through the negative regulation of the Glut1 (glucose transporter 1; SLC2A1 [Solute carrier 2A1]).”
BackgroundZhao, Q., Zhou, J., Li, F., Guo, S., Zhang, L. N., Li, J., Qi, Q., & Shi, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.910963 · Cited by 34
Yuan, H., Chen, C., Li, H., Qu, G., Chen, L., Liu, Y., Zhang, Y., Zhao, Q., Lian, C., Ji, A., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-023-01923-7 · Cited by 30
“As an essential enzyme in the creatine-biosynthetic pathway [22], GAMT can convert the glycine metabolite guanidoacetate to creatine, which mediates AMPK activation [23, 24].”
BackgroundCombination of imatinib and clotrimazole enhances cell growth inhibition in T47D breast cancer cells
Motawi, T. K., Sadik, N. A. H., Fahim, S. A., & Shouman, S. A. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.03.028 · Cited by 29
“Since oncogenic kinases replace growth factors so treatment with the kinase inhibitor IM may lead to reduced metabolism and p53-dependent cell death [16].”
BackgroundAzad, F., Nejati, V., Jalali, A. S., Najafi, G., & Rahmani, F. (2019) · Environmental Toxicology · doi:10.1002/tox.22737 · Cited by 32
“cellular stress and is known to mediate the cycle arrest in response to cellular stresses.(70,71) In continue, we assessed the Caspase-3 expression as a finisher of apoptosis.”
BackgroundMolecules from American Ginseng Suppress Colitis through Nuclear Factor Erythroid-2-Related Factor 2
Chaparala, A., Tashkandi, H., Chumanevich, A. A., Witalison, E. E., Windust, A. J., Cui, T., Nagarkatti, M., Nagarkatti, P. S., & Hofseth, L. J. (2020) · Nutrients · doi:10.3390/nu12061850 · Cited by 25
“This could be due to the effect of p53, which also plays an important role in the activation of antioxidant mechanisms like the synthesis of GSH and NADPH generation [35,36].”
BackgroundUncovering metabolism in rhabdomyosarcoma
Monti, E., & Fanzani, A. (2016) · Cell Cycle · doi:10.1080/15384101.2015.1071746 · Cited by 29
“In addition, NRF2 is a downstream target of p53, which also drives the expression of other several genes with antioxidant functions like sestrin, GSH peroxidase, aldehyde dehydrogenase, GLS2, TIGAR, and tumor protein p53-inducible nuclear protein 1 (TP53INP1).(93,114-119) Considering the central role of both NRF2 and…”
Loss of LKB1 in high‐grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53
Co, N. N., Iglesias, D. A., Celestino, J., Kwan, S., Mok, S. C., Schmandt, R. E., & Lu, K. H. (2014) · Cancer · doi:10.1002/cncr.28854 · Cited by 27
“In addition to its known role in cell cycle blockade and growth arrest in response to DNA damage and hypoxia, additional roles for p53 in the regulation of energy metabolism in response to stress recently have been described.(27,28) P53 activates AMPK expression and AMPK and tuberous sclerosis complex 1 (TSC1)/TSC2 ac…”
DNA methylation in genes associated with the evolution of ageing and disease: A critical review
Auley, M. T. M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101488 · Cited by 30
Metabolic Escape Routes of Cancer Stem Cells and Therapeutic Opportunities
Turdo, A., Porcelli, G., D’Accardo, C., Franco, S. D., Verona, F., Forte, S., Giuffrida, D., Memeo, L., Todaro, M., & Stassi, G. (2020) · Cancers · doi:10.3390/cancers12061436 · Cited by 28
Finch, E. R., Tukaramrao, D. B., Goodfield, L. L., Quickel, M. D., Paulson, R. F., & Prabhu, K. S. (2017) · Blood · doi:10.1182/blood-2016-08-736405 · Cited by 29
Kuwabara, S., Yamaki, M., Yu, H., & Itoh, M. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.06.079 · Cited by 24
Ponnusamy, L., Natarajan, S. R., & Manoharan, R. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30219 · Cited by 29
“In contrast, p53, a tumor suppressor protein facilitates mitochondrial oxidative phosphorylation and its loss of function that reduces oxidative phosphorylation and enhances aerobic glycolysis, leading to augmented cancer cell proliferation.(9) However, the regulatory mechanisms by which mTORC1/p53 coordinates cell me…”
BackgroundSocial isolation induces autophagy in the mouse mammary gland: link to increased mammary cancer risk
Sumis, A. M., Cook, K. L., Andrade, F. D. O., Hu, R., Kidney, E., Zhang, X., Kim, D., Carney, E., Nguyen, N., Yu, W., et al. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0359 · Cited by 28
“The metabolic markers included p53 because it regulates metabolism (Puzio-Kuter 2011), is elevated by social isolation (Filipovic et al.”
Samec, M., Mazuráková, A., Lučanský, V., Koklesová, L., Péčová, R., Péč, M. J., Golubnitschaja, O., AL-Ishaq, R. K., Čaprnda, M., Gašpar, Ľ., et al. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175655 · Cited by 23
Ahmed, C. M. S., Cui, Y., Frie, A. L., Burr, A., Kamath, R., Chen, J. Y., Rahman, A., Nordgren, T. M., Lin, Y., & Bahreini, R. (2019) · Environmental Science & Technology · doi:10.1021/acs.est.9b04376 · Cited by 25
Ibáñez-Cabellos, J. S., Seco-Cervera, M., Picher-Latorre, C., Pérez-Machado, G., García‐Giménez, J. L., & Pallardó, F. V. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118845 · Cited by 25
Metabolic sensors and their interplay with cell signalling and transcription
Krejčí, A. (2012) · Biochemical Society Transactions · doi:10.1042/bst20110767 · Cited by 23
Reyes‐Ruiz, A., Calvillo‐Rodríguez, K. M., Martínez‐Torres, A. C., & Rodríguez-Padilla, C. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01256-y · Cited by 26
Temre, M. K., Yadav, S., Goel, Y., Pandey, S. K., Kumar, A., & Singh, S. M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.925666 · Cited by 25
Haran, M. Z., & Gross, A. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.09.007 · Cited by 28
“In fact some proteins, such as p53 have a dual role and function both as metabolic regulators and cell cycle regulators (Puzio-Kuter, 2011).”
BackgroundHDAC6 deficiency induces apoptosis in mesenchymal stem cells through p53 K120 acetylation
Park, S.-Y., Phorl, S., Jung, S., Korm, S., Lee, S.-I., Noh, S., Han, M., Naskar, R., Kim, J., Choi, Y., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.10.087 · Cited by 21
Probing carbohydrate metabolism using hyperpolarized 13C‐labeled molecules
Singh, J., Suh, E. H., Sharma, G., Khemtong, C., Sherry, A. D., & Kovács, Z. Z. (2018) · NMR in Biomedicine · doi:10.1002/nbm.4018 · Cited by 23
“The tumor suppressor gene TP53 influences glycolysis at many points to regulate energy metabolism.(19) Intermediate metabolites produced in glycolysis are also used by branching pathways, such as the pentose phosphate pathway (PPP), glycogenesis, hexosamine synthesis pathways and serine biosynthesis to generate nucleo…”
BackgroundThe Role of DNA Damage Induced by Low/High Dose Ionizing Radiation in Cell Carcinogenesis
Jia, C., Wang, Q., Yao, X., & Yang, J. (2021) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2021.00020 · Cited by 20
Bogazzi, F., Raggi, F., Russo, D., Bohlooly‐Y, M., Sardella, C., Urbani, C., Lombardi, M., Manetti, L., Lupi, I., Törnell, J., et al. (2013) · Endocrinology · doi:10.1210/en.2013-1220 · Cited by 20
“However, depending on stress duration and the level of p53 expression, p53 may exert divergent effects, either promoting glycolysis or oxidative phosphorylation as well as inhibiting glycolysis, (24).”
BackgroundSood, A., Fernandes, V., Preeti, K., Rajan, S., Khatri, D. K., & Singh, S. B. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111278 · Cited by 22
AL-Duhaidahawi, D., Hasan, S. A., & Al-Zubaidy, H. F. S. (2020) · Current Diabetes Reviews · doi:10.2174/1573399817666201207200346 · Cited by 22
REDOX IMAGING OF THE p53-DEPENDENT MITOCHONDRIAL REDOX STATE IN COLON CANCER EX VIVO
Xu, H. N., Feng, M., Moon, L., Dolloff, N. G., El‐Deiry, W. S., & Li, L. Z. (2013) · Journal of Innovative Optical Health Sciences · doi:10.1142/s1793545813500168 · Cited by 19
“Our results show that: (1) both tumor lines have significant degree of intratumor heterogeneity of the redox state, typically exhibiting a distinct bi-modal distribution that either correlates with the spatial core–rim pattern or the “hot/cold” oxidation-reduction patches; (2) the p53−/− group is significantly more he…”
ResultInverse relationship between TCTP/RhoA and p53/ /cyclin A/actin expression in ovarian cancer cells
Kloc, M., Tejpal, N., Sidhu, J., Ganachari, M., Flores-Villanueva, P. O., Jennings, N. B., Sood, A. K., Kubiak, J. Z., & Ghobrial, R. M. (2012) · Folia Histochemica et Cytobiologica · doi:10.5603/19745 · Cited by 21
“Additionally, mutations in the TP53 gene may lead to aberrant cell proliferation and oncogenic transformation [10, 11, 13].”
BackgroundPan, P., Treat, M. D., & van Breukelen, F. (2014) · Journal of Experimental Biology · doi:10.1242/jeb.103614 · Cited by 21
“p53 has a role in regulating oxygen consumption and apoptosis as well as responses to hypoxia and nutrient deprivation (Vousden and Lane, 2007; Maddocks and Vousden, 2011; Puzio-Kuter, 2011).”
BackgroundIntroduction: The Changing Directions of p53 Research
Levine, A. J. (2011) · Genes & Cancer · doi:10.1177/1947601911413463 · Cited by 18
Human cellular mitochondrial remodelling is governed by miR-2909 RNomics
Malik, D., & Kaul, D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203614 · Cited by 20
Saeed, T., Ahmad, J., Kanwal, S., Holowatyj, A. N., Sheikh, I. A., Paracha, R. Z., Shafi, A., Siddiqa, A., Bibi, Z., Khan, M., et al. (2016) · PeerJ · doi:10.7717/peerj.2348 · Cited by 20
Human tripartite motif protein 52 is required for cell context-dependent proliferation
Benke, S., Agerer, B., Haas, L., Stöger, M., Lercher, A., Gabler, L., Kiss, I., Scinicariello, S., Berger, W., Bergthaler, A., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24422 · Cited by 18
Dembić, M., Andersen, H. S., Bastin, J., Doktor, T. K., Corydon, T. J., Sass, J. O., Costa, A. L., Djouadi, F., & Andresen, B. S. (2018) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2018.10.004 · Cited by 18
Harnessing p53 for targeted cancer therapy: new advances and future directions
Andrysík, Z., & Espinosa, J. M. (2025) · Transcription · doi:10.1080/21541264.2025.2452711 · Cited by 22
Machida, K. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7241 · Cited by 18
“This suggests that NANOG synergistically reprograms cellular metabolic pathways in the presence of p53 inactivation and b-catenin activation since p53 promotes glycolysis and OXPHOS (26, 55).”
BackgroundInhibition of Mdmx (Mdm4) in vivo induces anti-obesity effects
Kon, N., Wang, D., Li, T., Jiang, L., Qiang, L., & Gu, W. (2018) · Oncotarget · doi:10.18632/oncotarget.23837 · Cited by 17
“It has been suggested that p53 promote cell survival under transient metabolic stress, and p53 is known to lower glucose utilization and promotes mitochondrial respiration and fatty acid oxidation [3, 53].”
BackgroundDerous, D., Sahu, J., Douglas, A., Lusseau, D., & Wenzel, M. A. (2021) · Conservation Physiology · doi:10.1093/conphys/coaa136 · Cited by 22
“In response to limited nutrient availability the p53 signaling pathway can downregulate AKT/mTOR pathways (Puzio-Kuter, 2011), which in turn allows for more nutrient transporters to be expressed to the cell surface and increases uptake of nutrients (e.”
BackgroundWoolf, E. C., & Scheck, A. C. (2012) · CNS Oncology · doi:10.2217/cns.12.9 · Cited by 17
Fiorini, A., Sultana, R., Barone, E., Cenini, G., Perluigi, M., Mancuso, C., Cai, J., Klein, J. B., St. Clair, D., & Butterfield, D. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049846 · Cited by 16
“p53 plays an additional role in the regulation of glutamate metabolism activating the expression of glutaminase 2 which provides glutamate to promote the tricarboxylic acid (TCA) cycle and oxidative phosphorylation [59].”
BackgroundPark, S. J., Cerella, C., Kang, J. M., Byun, J., Kum, D., Orlikova-Boyer, B., Lorant, A., Schnekenburger, M., Al‐Mourabit, A., Christov, C., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03372-0 · Cited by 18
“When TP53 is mutated, repression of GLUT1 and GLUT4 is lost, leading to increased glycolysis, proliferation, and energy supply [89].”
Social Isolation and Breast Cancer
Hilakivi-Clarke, L. A., & Andrade, F. D. O. (2023) · Endocrinology · doi:10.1210/endocr/bqad126 · Cited by 23
p53 terminates the regenerative fetal-like state after colitis-associated injury
Hartl, K., Bayram, Ş., Wetzel, A., Harnack, C., Lin, M., Fischer, A., Liu, L., Beccaceci, G., Mastrobuoni, G., Geisberger, S., et al. (2024) · Science Advances · doi:10.1126/sciadv.adp8783 · Cited by 21
“Our data reveal that the regenerative state is associated with high levels of glycolytic metabolism, at least partly due to increased levels of PKM2, the final rate-limiting enzyme of glycolysis, which is typically expressed in fetal tissues and cancers ( 46 – 48 ).”
Bayesian Pathway Analysis of Cancer Microarray Data
Korucuoglu, M., Isci, S., Özgür, A., & Otu, H. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102803 · Cited by 19
“There have been other additional studies that have shown the relation of adipocytokine signaling pathway to lung and liver cancers [59,60].”
ResultMitchell, R. D., Wallace, A. D., Hodgson, E., & Roe, R. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102104 · Cited by 17
“It carefully balances glycolysis and oxidative phosphorylation as well as the autophagy pathway; dysregulation of the p53 pathway can have a profound influence on the behavior of normal and diseased cells [43,44].”
Lim, J. Y., Liu, C., Hu, K., Smith, D. E., Wu, D., Lamon‐Fava, S., Ausman, L. M., & Wang, X. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900949 · Cited by 16
Fernández-Calero, T., Davyt, M., Perelmuter, K., Chalar, C., Bampi, G., Persson, H., Tosar, J. P., Hafstað, V., Naya, H., Rovira, C., et al. (2020) · Cancer & Metabolism · doi:10.1186/s40170-020-00216-7 · Cited by 18
Yang, J., Ma, W., Mei, Q., Song, J., Shu, L., Zhang, S., Li, C., Liu, A., Du, N., & Shi, Z. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00053 · Cited by 19
Alhaddad, L., Pustovalova, M. V., Blokhina, T., Chuprov‐Netochin, R. N., Osipov, A. N., & Leonov, S. V. (2021) · Cancers · doi:10.3390/cancers13112669 · Cited by 16
“p53 can regulate many different biological pathways, and its loss can lead to alterations in cellular metabolism [27].”
BackgroundLyu, M., Wang, Y., Chen, Q., Qin, J., Hou, D., Huang, S., Shao, D., Gong, X., Huang, G., Zhang, S., et al. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s349950 · Cited by 24
“TP53 is a tumor suppressor protein characterized by the regulation of glycolysis and oxidative phosphorylation, which is involved in several aspects of human function.(55) According to reports, the serum level of IL-1β was associated with TP53 expression, and the high level of IL-1β might indicate the exacerbation of…”
BackgroundEmerging Molecular Targets for Anti-proliferative Strategies in Pulmonary Arterial Hypertension
Tu, L., & Guignabert, C. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-38664-0_17 · Cited by 20
Antoun, S., Atallah, D. M., Tahtouh, R., Alaaeddine, N., Moubarak, M., Khaddage, A., Ayoub, E. N., Chahine, G., & Hilal, G. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0514-2 · Cited by 20
“Mutations affecting the DNA binding domain of TP53 decrease the ability of p53 to regulate the expression of glucose transporters, which increases glucose metabolism and energetic supply [15].”
Oh, I., Raymundo, B. R., Kim, M. J., & Kim, C. (2020) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2019.1676692 · Cited by 16
“This intricate occurrence in tumor development is commonly associated with decreased P53 expression [32,37].”
BackgroundXia, J., Chen, S., Li, Y., Li, H., Gan, M., Wu, J., Prohaska, C. C., Bai, Y., Gao, L., Gu, L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.798538 · Cited by 16
“The p53 signaling pathway is also identified, which plays an important role in restoring the proliferation of cells that have DNA damage (75, 76).”
BackgroundElectrophoretic Mobility Shift Assay: Analyzing Protein - Nucleic Acid Interactions
Alves, C., & Cunh, C. (2012) · InTech eBooks · doi:10.5772/37619 · Cited by 14
“…in development and progression of diseases is perhaps the p53 protein. p53 is a transcription factor involved in the modulation of expression of several genes that regulate essential cellular processes such as cell proliferation, apoptosis, and DNA damage repair (reviewed by Puzio-Kuter, 2011).”
BackgroundMcGowan, E. M., Lin, Y., & Hatoum, D. (2018) · Cancers · doi:10.3390/cancers10060172 · Cited by 15
Oncogenic role of ABHD5 in endometrial cancer
Zhou, Q., Wang, F., Zhou, K., Huang, K., Zhu, Q., Luo, X., Yu, J., & Shi, Z. (2019) · Cancer Management and Research · doi:10.2147/cmar.s188648 · Cited by 14
Afkhami‐Ardakani, M., Hasanzadeh, S., Shahrooz, R., Delirezh, N., & Malekinejad, H. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13854 · Cited by 18
FKBP4 promotes glycolysis and hepatocellular carcinoma progression via p53/HK2 axis
Zeng, Z., Xu, S., Wang, R., & Han, X. (2024) · Scientific Reports · doi:10.1038/s41598-024-78383-6 · Cited by 16
Molecular Mechanisms of Cellular Senescence in Age-Related Endometrial Dysfunction
Kobayashi, H., Umetani, M., Nishio, M., Shigetomi, H., Imanaka, S., & Hashimoto, H. (2025) · Cells · doi:10.3390/cells14120858 · Cited by 17
Moore, E. S., Daugherity, E. K., Karambizi, D. I., Cummings, B. P., Behling‐Kelly, E. L., Schaefer, D. M. W., Southard, T. L., McFadden, J. W., & Weiss, R. S. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005729 · Cited by 13
McCubrey, J. A., Meher, A. K., Akula, S. M., Abrams, S. L., Steelman, L. S., LaHair, M. M., Franklin, R. A., Martelli, A. M., Ratti, S., Cocco, L., et al. (2022) · Aging · doi:10.18632/aging.204038 · Cited by 12
Kianifard, D., Shoar, S. M. M., Karkan, M. F., & Aly, A. (2021) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v19i2.8475 · Cited by 20
“The p53 is often upregulated after DNA damage resulting in the initiation of apoptosis (31, 32).”
BackgroundDuan, L., Perez, R. E., Lai, X., Chen, L., & Maki, C. G. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.007122 · Cited by 12
“Cancer cells often have an altered metabolism that includes increased glucose uptake and glycolysis and reduced oxidative phosphorylation. p53 can inhibit glycolysis by repressing expression of glycolytic enzyme genes and promote oxidative phosphorylation by increasing expression of genes like SCO2 (15, 16).”
BackgroundRoles of lncRNAs related to the p53 network in breast cancer progression
Song, J., Cui, Q., & Gao, J. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1453807 · Cited by 10
“5) in fl uences cellular metabolism by regulating genes involved in glycolysis, oxidative phosphorylation, and antioxidant defense (32).”
BackgroundFundu, T. M., Kapepula, P. M., Mboloko, J. E., Remacle, J., & Ngombe, N. K. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.89384 · Cited by 21
Pang, J.-L., Huang, F.-H., Zhang, Y., Wu, Y. Z., Ge, X., Li, S., & Li, X. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115726 · Cited by 12
Cross Talk between the Circadian Clock Proteins and TP53 in Cancer and Therapeutic Significance
Valafar, B., Zaravinos, A., & Bonavida, B. (2021) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2022042860 · Cited by 14
RK, A. R. A., Arumugam, S., Muninathan, N., Baskar, K., Deepthi, S., & Dinesh Roy, D. (2024) · Cureus · doi:10.7759/cureus.60125 · Cited by 12
“Because of this, p53 helps a cell adapt to and survive minor metabolic stress [16].”
BackgroundStructural-functional diversity of p53 proteoforms
Naryzhny, S., & Legina, O. K. (2019) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20196504263 · Cited by 10
Garranzo‐Asensio, M., Rodríguez‐Cobos, J., Millán, C. S., Poves, C. F., Fernández‐Aceñero, M. J., Pastor‐Morate, D., Viñal, D., Montero‐Calle, A., Solís‐Fernández, G., Ceron, M., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13228 · Cited by 10
Ghrelin regulating liver activity and its potential effects on liver fibrosis and Echinococcosis
Zhu, J., Zhou, T., Meng, M., Aimulajiang, K., & Wen, H. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1324134 · Cited by 12
“At the hypothalamic level, Ghrelin can regulate Sirtuin1 to deacetylate p53 (Puzio-Kuter, 2011; Vela ́ squez et al., 2011), stimulate AMPK phosphorylation and inhibit mTOR/PPAR g signaling pathway (Budanov and Karin, 2008; Cariou et al., 2012; Li et al., 2014), thereby up-regulating the expression…”
Backgroundp53 Mediates impaired insulin signaling in 3T3‐L1 adipocytes during hyperinsulinemia
kumari, P. J., Selvaraju, S., Sangeetha, K. N., Baskaran, S. K., & Lakshmi, B. S. (2014) · Cell Biology International · doi:10.1002/cbin.10275 · Cited by 10
“…bromide 818 Cell Biol Int 38 (2014) 818–824 © 2014 International Federation for Cell Biology transcribes a group of genes that negatively regulates IGF/ Akt/mTOR pathway (Fenq, 2010). p53 also modulates cellular metabolic adaptation during nutritional starvation in cancer cells (Puzio-Kuter, 2011).”
BackgroundKong, L., Murata, M. M., & Digman, M. A. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.01.026 · Cited by 11
“This p53-mediated regulation of metabolism occurs through its promotion of target genes such as glutaminase 2 and TIGAR to upregulate oxphos and down-regulate glycolysis, respectively [12].”
BackgroundKolossov, V. L., Hanafin, W. P., Beaudoin, J. N., Bica, D. E., DiLiberto, S. J., Kenis, P. J. A., & Gaskins, H. R. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214522179 · Cited by 12
“For instance, activation by p53 of a mitochondrial glutaminase facilitates hydrolysis of glutamine to glutamate, which in turn can be used to generate GSH leading to an increased GSH/GSSG ratio.(36) Mutations of the p53 gene and consequent post-translational alterations of the p53 protein are frequently observed in a…”
MethodMilk and Parkinson disease: Could galactose be the missing link
Sarni, A. R., & Baroni, L. (2018) · Mediterranean Journal of Nutrition and Metabolism · doi:10.3233/mnm-180234 · Cited by 15
High glucose-induced human cellular immune response is governed by miR-2909 RNomics
Kaul, D., & Sharma, S. (2015) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2015.01.009 · Cited by 8
Dashtiyan, A. A., Sepehrimanesh, M., Tanideh, N., & Afzalpour, M. E. (2017) · Biochimie Open · doi:10.1016/j.biopen.2017.03.005 · Cited by 8
Perspectives on immunometabolism at the biomaterials interface
Macias, S. L., & Keselowsky, B. G. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.100992 · Cited by 8
Identification of 20(S)‐Ginsenoside Rh2 as a Potential EGFR Tyrosine Kinase Inhibitor
Liang, Y., Zhao, J., Zou, H., Zhang, J., & Zhang, T. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6119737 · Cited by 8
“Activation of the p53 can lead to cell cycle arrest and cell apoptosis [47].”
NAD+ depletion enhances reovirus-induced oncolysis in multiple myeloma
Kennedy, B. E., Giacomantonio, M., Murphy, J. P., Cutler, S. D., Sadek, M., Konda, P., Paulo, J. A., Pathak, G. P., Renkens, S. H. J., Grieve, S., et al. (2022) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2022.02.017 · Cited by 11
“Functional p53 and mutated KRAS are known to have counteractive effects on several pathways including metabolism; p53 favors oxidative phosphorylation, and mutated KRAS favors aerobic glycolysis.(33,34) Indeed, p53-repressed glycolytic enzymes PFKP and PFKM negatively correlated with sensitivity to combination therapy…”
BackgroundHoang, D. H., Morales, C. J., Rodriguez, I. R., Valerio, M., Guo, J., Chen, M.-H., Wu, X., Horne, D. A., Gandhi, V. V., Chen, L. S., et al. (2022) · Cancers · doi:10.3390/cancers14061446 · Cited by 12
“Previous studies reported that p53 promotes OXPHOS [31].”
BackgroundThabet, N. M., Abdel-Rafei, M. K., El-Sayyad, G. S., Elkodous, M. A., Shaaban, A., Du, Y.-C., Rashed, L. A., & Askar, M. A. (2022) · Cancer Nanotechnology · doi:10.1186/s12645-022-00122-1 · Cited by 7
“(2019) demonstrated that MgO and Fe2O3 nanoparticles induce apoptosis in cancer cells through increasing the load of intracellular ROS.”
BackgroundInfluentialROS, Redox Regulation, and Anticancer Therapy
Bansal, M. P. (2023) · Springer eBooks · doi:10.1007/978-981-99-7342-2_9 · Cited by 15
Illangeswaran, R. S. S., Jebanesan, D. Z. P., Sivakumar, K. K., Vidhyadharan, R. T., Rajamani, B. M., Arthur, N. B. J., David, E. K., Velayudhan, S. R., Mathews, V., & Balasubramanian, P. (2023) · Leukemia Research · doi:10.1016/j.leukres.2023.107054 · Cited by 8
Wong, T., Chen, Y.-H., Liu, S.-H., Solís, M. A., Yu, C.-H., Chang, C., & Huang, L. L. H. (2015) · Stem Cells International · doi:10.1155/2016/2809192 · Cited by 7
“However, the role of p53 is complicated such that it regulates not only DNA damage response, but also energy metabolism glycolysis and oxidative stress [61].”
So, V., Jalan, D., Lemaire, M. J., Topham, M. K., Hatch, G. M., & Epand, R. M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.09.021 · Cited by 7
Lin, S., Chen, M., Lin, S., Huang, X., Chen, W., & Wu, S. (2024) · Medicine · doi:10.1097/md.0000000000040391 · Cited by 6
“[36] Some studies in literature have shown that TP53 is related to senescence of epithelial cell and can increase the susceptibility and severity When the energy contribution of a residue is a negative value, it indicates that there is a favorable interaction between the residue and the ligand that…”
BackgroundIslam, M. T., Raihan, M. O., Akter, A., Ferdous, J., Begum, S., Rakib, M. A., Molla, N. U., Datta, P., Sikdar, B., Rehman, S., et al. (2025) · ChemistrySelect · doi:10.1002/slct.202404160 · Cited by 6
MicroRNA regulating metabolic reprogramming in tumor cells: New tumor markers
Felipe‐Abrio, B., & Otero-Albiol, D. (2016) · Cancer translational medicine · doi:10.4103/2395-3977.196909 · Cited by 7
Lanza, M., Basilotta, R., Cuzzocrea, S., Bulzomì, M., Oddo, S., Casili, G., & Esposito, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411303 · Cited by 7
Activation of proline metabolism maintains ATP levels during cocaine-induced polyADP-ribosylation
Dash, S., Dash, C., & Pandhare, J. (2021) · Amino Acids · doi:10.1007/s00726-021-03065-w · Cited by 5
“2019; Humpton and Vousden 2019; Puzio-Kuter 2011). p53 mediates this regulation via the induction of several target genes collectively known as p53induced genes (PIGs).”
BackgroundSchmitt, M., Sinnberg, T. W., Niessner, H., Forschner, A., Garbe, C., Maček, B., & Nalpas, N. (2021) · Cancers · doi:10.3390/cancers13215411 · Cited by 7
“TP53 is frequently mutated in several cancer types including melanoma and many metabolic pathways are regulated by TP53, influencing energy metabolism and the growth of cancer cells [52].”
Background
Metadata
- Authors
- Puzio-Kuter, A. M.
- Venue
- Genes & Cancer
- Publisher
- SAGE Publications
- Published
- 2011-04-01
- Volume
- 2
- Issue
- 4
- Pages
- 385-391
- ISSN
- 1947-6019 (ISSN-L)
- 1947-6027
- PMC
- PMC3135642
- OpenAlex
- W2147294934
- Cited by
- 273
- References
- 60
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 20 · 2023: 13 · 2022: 23 · 2021: 21 · 2020: 26 · 2019: 21 · 2018: 21 · 2017: 24 · 2016: 17 · 2015: 18 · 2014: 24 · 2013: 9 · 2012: 14
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Genes & Cancer (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- p53, tumor suppressor, cancer metabolism, aerobic glycolysis, oxidative phosphorylation, metabolic reprogramming, energy metabolism, oxidative stress, DNA damage response, hypoxia, oncogenes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.